Novocuff develops a medical device that monitors uterine contractions to identify women at risk of preterm birth. By providing real-time data, the device aims to improve pregnancy outcomes and reduce the incidence of premature deliveries.
Funding
$26.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AIFounders
Product
Problem
Current methods for monitoring uterine contractions to predict preterm birth are often inaccurate or require frequent clinic visits, leading to delayed intervention and increased risk for premature deliveries. Existing technologies may not provide continuous, real-time data, hindering timely clinical decision-making.
Solution
Novocuff has developed a non-invasive, wearable medical device that continuously monitors uterine contractions to identify women at risk of preterm labor. The device uses advanced sensor technology to capture and transmit real-time data on contraction patterns. This data is then analyzed using proprietary algorithms to provide clinicians with actionable insights into a patient's risk profile. By enabling early detection and intervention, Novocuff aims to improve pregnancy outcomes and reduce the incidence of premature births.
Target Audience
The primary target audience includes obstetricians, maternal-fetal medicine specialists, and hospitals focused on improving prenatal care and reducing preterm birth rates.
Features
- Non-invasive, wearable sensor for continuous monitoring of uterine contractions
- Real-time data transmission to a secure cloud platform
- Proprietary algorithms for analyzing contraction patterns and predicting preterm labor risk
- Clinician dashboard for visualizing data and receiving alerts